Vaxart's market cap is currently $82.18M. The company's EPS TTM is $-0.07; its P/E ratio is ―; Vaxart is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
